🧬 Cancer: A Comprehensive Overview of Types, Causes, Diagnosis, Treatment, and Survival
Cancer is a broad term encompassing a large group of diseases characterized by the uncontrolled growth and spread of abnormal cells. These cells can invade nearby tissues and travel to distant organs through the bloodstream or lymphatic system, a process called metastasis. Cancer is a leading cause of death worldwide, but advances in prevention, early detection, and treatment have significantly improved outcomes for many patients.
Contents
- 1. 🧬 Cancer: A Comprehensive Overview of Types, Causes, Diagnosis, Treatment, and Survival
- 2. 🔬 What Is Cancer? Definition and ICD-10 Classification
- 3. 🧬 Types of Cancer
- 4. ⚠️ What Causes Cancer? Risk Factors and Carcinogens
- 5. 🛡️ How to Avoid and Prevent Cancer
- 6. 🚨 Symptoms and Early Warning Signs
- 7. 🩺 Diagnosis: CT, MRI, PET, and Biopsy
- 8. 💊 Treatment: Chemotherapy, Surgery, Radiation, Immunotherapy, and Targeted Therapy
- 9. 📊 Stages of Cancer: The TNM System
- 10. 🌐 Metastasis: The Spread of Cancer
- 11. 📈 Cure Rate and Survival Rate
- 12. ⏳ Life Expectancy With and Without Treatment
- 13. 📌 Facts and Statistics
- 14. ❓ Questions and Answers
- 15. 🎯 Key Takeaways and Conclusions
- 16. 📚 References
This article provides an in-depth, evidence-based overview of cancer, covering its classification, causes, prevention strategies, symptoms, diagnostic methods, treatment modalities, staging, metastatic process, survival statistics, and frequently asked questions.
🔬 What Is Cancer? Definition and ICD-10 Classification
Cancer, also referred to as a malignant neoplasm or malignant tumor, is a disease in which abnormal cells divide without control and are able to invade other tissues. Normal cells follow a regulated cycle of growth, division, and death. Cancer cells evade these regulatory mechanisms, leading to unchecked proliferation.
The International Classification of Diseases, Tenth Revision (ICD-10) provides a standardized coding system for all diseases, including cancers. Malignant neoplasms are classified under the code range C00–C97. This range covers:
-
C00–C75: Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue.
-
C76–C80: Malignant neoplasms of ill-defined, secondary, and unspecified sites.
-
C81–C96: Malignant neoplasms stated or presumed to be primary, of lymphoid, haematopoietic and related tissue.
-
C97: Malignant neoplasms of independent (primary) multiple sites.
Examples of specific ICD-10 codes include C50 for breast cancer, C34 for lung cancer, C18–C20 for colorectal cancer, and C61 for prostate cancer. This coding system is essential for cancer registries, epidemiological research, and clinical documentation.
🧬 Types of Cancer
Cancers are classified primarily by the type of cell from which they originate. The main categories include:
🩸 Carcinoma
Carcinomas are the most common type of cancer, accounting for approximately 80–90% of all cases. They arise from epithelial cells, which line the surfaces of organs and body cavities. Common carcinomas include:
-
Adenocarcinoma: Originates in glandular tissue (e.g., breast, colon, prostate).
-
Squamous cell carcinoma: Arises in squamous epithelium (e.g., skin, esophagus, lungs).
-
Basal cell carcinoma: A type of skin cancer.
-
Transitional cell carcinoma: Found in the lining of the bladder, ureters, and kidneys.
🦴 Sarcoma
Sarcomas are rare cancers that develop from mesenchymal cells, which form connective tissues such as bone, cartilage, fat, muscle, and blood vessels. Examples include osteosarcoma (bone), liposarcoma (fat), and leiomyosarcoma (smooth muscle).
🛡️ Lymphoma and Myeloma
These cancers originate in the cells of the immune system, particularly lymphocytes and plasma cells. Hodgkin lymphoma and non-Hodgkin lymphoma are the two main groups. Multiple myeloma arises from plasma cells in the bone marrow.
🩸 Leukemia
Leukemias are cancers of the blood-forming tissues, including the bone marrow and lymphatic system. They are characterized by the overproduction of abnormal white blood cells. Major types include acute lymphocytic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML).
🧠 Central Nervous System Cancers
These include tumors of the brain and spinal cord, such as gliomas, meningiomas, and medulloblastomas.
👶 Pediatric Cancers
Cancers in children and adolescents are often distinct from adult cancers. The most common pediatric cancers include leukemia, brain tumors, lymphomas, and neuroblastoma.
The most common cancers globally, by new cases, are lung cancer (2.6 million cases), breast cancer (2.4 million), colorectal cancer (2.0 million), prostate cancer (1.5 million), non-melanoma skin cancer (1.1 million), and gastric cancer (1.0 million).
⚠️ What Causes Cancer? Risk Factors and Carcinogens
Cancer develops through a multi-step process in which normal cells transform into malignant cells. This transformation results from the interaction between an individual’s genetic makeup and external agents, known as carcinogens. It is important to note that having a risk factor does not guarantee developing cancer; it simply increases the likelihood.
🧬 Genetic and Hereditary Factors
Some cancers are linked to inherited gene mutations. For example, mutations in the BRCA1 and BRCA2 genes significantly increase the risk of breast and ovarian cancers. Other hereditary cancer syndromes include Lynch syndrome (colorectal cancer) and Li-Fraumeni syndrome (multiple cancer types).
🚬 Environmental and Lifestyle Risk Factors
Tobacco use is the single largest preventable cause of cancer worldwide, linked to cancers of the lung, mouth, throat, esophagus, kidney, and bladder. Alcohol consumption is associated with cancers of the mouth, throat, esophagus, liver, and breast.
Diet and obesity play a significant role. High-fat diets and low intake of fruits and vegetables are associated with increased risk of colorectal and breast cancers. Processed meats are classified as carcinogenic.
Physical inactivity and obesity are independent risk factors for several cancers, including colorectal, breast (postmenopausal), endometrial, and kidney cancers.
🦠 Infectious Agents
Approximately 5–10% of cancers are linked to infections. Key oncogenic pathogens include:
-
Human papillomavirus (HPV): Causes cervical, anal, and oropharyngeal cancers.
-
Hepatitis B and C viruses: Linked to liver cancer.
-
Helicobacter pylori: Associated with gastric cancer.
-
Epstein-Barr virus: Linked to Burkitt lymphoma and nasopharyngeal carcinoma.
☢️ Physical Carcinogens
Ionizing radiation (X-rays, gamma rays, radon) and ultraviolet (UV) radiation from sunlight are well-established carcinogens. Radon exposure in homes is a leading cause of lung cancer in non-smokers.
🧪 Chemical Carcinogens
Occupational and environmental exposure to chemicals such as asbestos, benzene, chromates, nickel, vinyl chloride, and certain pesticides increases cancer risk. Air pollution is also a significant risk factor, particularly for lung cancer.
🛡️ How to Avoid and Prevent Cancer
Prevention is the most effective long-term strategy against cancer. It is estimated that 30–50% of all cancers are preventable through lifestyle modifications and public health interventions.
🚭 Primary Prevention
Avoid tobacco: Smoking cessation at any age reduces cancer risk. After 10 years of quitting, the risk of lung cancer drops by half.
Limit alcohol: The World Health Organization recommends reducing or eliminating alcohol consumption.
Maintain a healthy weight: Obesity is linked to at least 13 types of cancer. A balanced diet rich in fruits, vegetables, and whole grains, combined with regular physical activity, is recommended.
Protect against infections: HPV vaccination prevents cervical and other HPV-related cancers. Hepatitis B vaccination reduces liver cancer risk.
Avoid excessive sun exposure: Use sunscreen, wear protective clothing, and avoid tanning beds.
Reduce occupational exposure: Follow workplace safety guidelines to minimize contact with known carcinogens.
🔍 Secondary Prevention: Screening and Early Detection
Screening aims to detect cancer before symptoms appear, when treatment is most effective. The US Preventive Services Task Force (USPSTF) recommends screening for several cancers:
| Cancer Type | Screening Method | Recommended Population |
|---|---|---|
| Breast | Mammography | Women aged 40–74, every 2 years |
| Cervical | Pap test / HPV test | Women aged 21–65 |
| Colorectal | Colonoscopy, FIT, etc. | Adults aged 45–75 |
| Lung | Low-dose CT (LDCT) | Adults aged 50–80 with heavy smoking history |
Screening can detect precancerous lesions (e.g., colon polyps, cervical dysplasia) that can be removed before they become malignant. Early detection of breast, cervical, colorectal, and lung cancers has been shown to save lives.
🚨 Symptoms and Early Warning Signs
Cancer can cause a wide range of symptoms, some subtle and some obvious. Many symptoms are nonspecific and may be caused by benign conditions, but persistent or unexplained changes should prompt medical evaluation.
⚠️ General Warning Signs
The American Cancer Society and other organizations have identified common warning signs:
-
Unexplained weight loss
-
Persistent fatigue
-
Night sweats and fever
-
Loss of appetite
-
New, persistent pain
-
Changes in bowel or bladder habits
-
Blood in urine or stool
-
Abnormal vaginal bleeding
-
A new lump or mass
-
Changes in the size, shape, or color of a mole
-
A sore that does not heal
-
Difficulty swallowing or persistent indigestion
-
Chronic cough or hoarseness.
🎯 Site-Specific Symptoms
-
Lung cancer: Persistent cough, coughing up blood, shortness of breath, chest pain.
-
Breast cancer: Painless lump, nipple discharge, skin dimpling.
-
Colorectal cancer: Rectal bleeding, change in bowel habits, abdominal discomfort.
-
Prostate cancer: Difficulty urinating, blood in semen, pelvic discomfort.
-
Cervical cancer: Abnormal vaginal bleeding, pelvic pain.
-
Skin cancer: New or changing mole, sore that does not heal.
Early detection significantly improves the chances of successful treatment. Any persistent symptom lasting more than two weeks should be evaluated by a healthcare professional.
🩺 Diagnosis: CT, MRI, PET, and Biopsy
Diagnosing cancer involves a combination of clinical evaluation, imaging studies, laboratory tests, and tissue analysis.
🖥️ Imaging Techniques
Computed Tomography (CT): CT scans use X-rays to produce detailed cross-sectional images of the body. They are widely used to detect tumors, assess their size and location, and guide biopsies. CT is particularly useful for lung, liver, and pancreatic cancers.
Magnetic Resonance Imaging (MRI): MRI uses strong magnetic fields and radio waves to generate detailed images of soft tissues. It is especially valuable for brain, spinal cord, and musculoskeletal tumors, as well as for evaluating breast and prostate cancers.
Positron Emission Tomography (PET): PET scans detect metabolic activity by tracking the uptake of a radioactive glucose analog (FDG). Cancer cells typically have higher metabolic rates, making PET useful for detecting metastases and assessing treatment response. PET is often combined with CT (PET/CT) for improved anatomical detail.
Ultrasound: Uses high-frequency sound waves to visualize internal organs. It is commonly used for breast, thyroid, and abdominal cancers.
Mammography: A specialized X-ray of the breast used for breast cancer screening and diagnosis.
🔬 Biopsy
A biopsy is the definitive method for cancer diagnosis. It involves removing a sample of tissue for examination under a microscope by a pathologist. Biopsies can be:
-
Fine-needle aspiration (FNA): Uses a thin needle to extract cells.
-
Core needle biopsy: Removes a small cylinder of tissue.
-
Surgical biopsy: Removes part or all of a tumor.
Biopsy results provide information about the cancer type, grade, and molecular characteristics, which guide treatment decisions.
🩸 Blood Tests and Tumor Markers
Blood tests can detect tumor markers—substances produced by cancer cells or by the body in response to cancer. Examples include PSA (prostate cancer), CA-125 (ovarian cancer), CEA (colorectal cancer), and AFP (liver cancer). Tumor markers are not used alone for diagnosis but can aid in monitoring treatment response and detecting recurrence.
💊 Treatment: Chemotherapy, Surgery, Radiation, Immunotherapy, and Targeted Therapy
Cancer treatment is multimodal, meaning it often combines several approaches. The choice of treatment depends on cancer type, stage, molecular characteristics, and the patient’s overall health.
🔪 Surgery
Surgery remains the primary curative treatment for many solid tumors. It involves the physical removal of the tumor and, in some cases, surrounding tissues and lymph nodes. Surgery is most effective for localized cancers before they have spread. Neoadjuvant chemotherapy or radiation may be used before surgery to shrink tumors, while adjuvant therapy is given after surgery to eliminate residual cancer cells.
☢️ Radiation Therapy
Radiation therapy uses high-energy beams (X-rays, protons) to destroy cancer cells by damaging their DNA. It is used for localized cancers, often in combination with surgery or chemotherapy. Radiation can be delivered externally (external beam radiation) or internally (brachytherapy). It is particularly effective for prostate, breast, lung, and head and neck cancers.
💊 Chemotherapy
Chemotherapy uses cytotoxic drugs that target rapidly dividing cells. It is a systemic treatment, meaning it affects the entire body, making it effective for metastatic cancers. Chemotherapy is often used in combination regimens to maximize efficacy. Common side effects include nausea, vomiting, hair loss, fatigue, increased infection risk, and mouth sores. These side effects occur because chemotherapy affects normal rapidly dividing cells as well.
🎯 Targeted Therapy
Targeted therapies interfere with specific molecular targets involved in cancer growth and progression. Unlike traditional chemotherapy, they are designed to selectively attack cancer cells with minimal damage to normal cells. Examples include HER2 inhibitors (trastuzumab for breast cancer), EGFR inhibitors (erlotinib for lung cancer), BRAF inhibitors (vemurafenib for melanoma), and CDK4/6 inhibitors (palbociclib for breast cancer).
🛡️ Immunotherapy
Immunotherapy harnesses the body’s immune system to fight cancer. Key approaches include:
-
Immune checkpoint inhibitors (e.g., pembrolizumab, nivolumab): Block proteins that prevent T cells from attacking cancer.
-
CAR-T cell therapy: Genetically engineers a patient’s T cells to target cancer.
-
Monoclonal antibodies: Bind to specific cancer cell antigens.
-
Cancer vaccines: Stimulate immune response against cancer cells.
Immunotherapy has revolutionized the treatment of melanoma, lung cancer, and several other malignancies.
🧬 Hormone Therapy
Hormone therapy is used for hormone-sensitive cancers, such as breast and prostate cancers. It works by blocking hormone production or action.
🩸 Stem Cell Transplantation
Used primarily for hematologic malignancies (leukemia, lymphoma, myeloma), this involves replacing diseased bone marrow with healthy stem cells.
📊 Stages of Cancer: The TNM System
Cancer staging describes the extent of cancer in the body. The most widely used system is the TNM system, developed by the American Joint Committee on Cancer (AJCC) and the Union for International Cancer Control (UICC).
-
T (Tumor): Describes the size and extent of the primary tumor (T0–T4).
-
N (Nodes): Indicates whether cancer has spread to nearby lymph nodes (N0–N3).
-
M (Metastasis): Indicates whether cancer has spread to distant organs (M0 or M1).
Based on TNM, cancers are grouped into stages:
-
Stage 0: Carcinoma in situ (CIS), abnormal cells confined to their original location.
-
Stage I: Localized cancer, small and not spread.
-
Stage II: Locally advanced cancer, larger or with limited lymph node involvement.
-
Stage III: Further local and regional spread.
-
Stage IV: Metastatic cancer, spread to distant organs.
Staging is critical for determining prognosis and selecting the most appropriate treatment.
🌐 Metastasis: The Spread of Cancer
Metastasis is the process by which cancer cells spread from the primary tumor to distant organs. It is responsible for the majority of cancer-related deaths.
The metastatic cascade involves several steps:
-
Local invasion: Cancer cells break through surrounding tissue.
-
Intravasation: Cells enter the bloodstream or lymphatic system.
-
Circulation: Cells travel through the body.
-
Arrest and extravasation: Cells lodge in capillaries and exit into new tissue.
-
Colonization: Cells grow in the new organ, forming secondary tumors.
Common sites of metastasis include the lungs, liver, bones, brain, and lymph nodes . The specific pattern of metastasis depends on the cancer type (organotropism). For example, colorectal cancer often metastasizes to the liver, while breast cancer commonly spreads to bone, lung, liver, and brain.
📈 Cure Rate and Survival Rate
Survival rates for cancer have improved dramatically over the past decades. The 5-year relative survival rate for all cancers combined in the United States has reached 70% for people diagnosed between 2015 and 2021, up from about 50% in the mid-1970s.
Survival varies widely by cancer type and stage:
-
Localized cancers (confined to the primary site) have the highest survival rates, often exceeding 90% for many types. For localized breast cancer, the 5-year survival rate is >99%.
-
Regional cancers (spread to nearby lymph nodes) have intermediate survival rates, around 60–85% depending on the type.
-
Distant (metastatic) cancers have lower survival rates, but even here, advances in treatment have improved outcomes. For distant breast cancer, the 5-year survival rate is approximately 32%.
It is important to note that survival rates are statistical averages and do not predict individual outcomes. Many factors, including age, overall health, tumor biology, and response to treatment, influence prognosis.
⏳ Life Expectancy With and Without Treatment
Untreated cancer typically has a poor prognosis, but the specific life expectancy varies by cancer type, stage, and patient factors.
Studies of untreated cancers show:
-
For untreated head and neck squamous cell carcinoma, the median survival is approximately 20.5 weeks, with 90% of patients succumbing within one year.
-
Untreated metastatic breast cancer patients have a median survival of around 12 months.
-
For untreated operable alimentary tract cancers, 5-year survival rates range from 4–10% depending on the stage.
With modern treatment, outcomes are dramatically better. For example, the 5-year survival rate for all cancers combined is now 70%. Even for metastatic cancers, targeted therapies and immunotherapy have extended survival for many patients.
📌 Facts and Statistics
-
Cancer is the second leading cause of death globally, after cardiovascular disease.
-
In 2024, an estimated 20.6 million new cancer cases and 9.8 million cancer deaths occurred worldwide.
-
Without urgent action, annual cancer cases are projected to rise to nearly 35 million by 2050.
-
Lung cancer is the leading cause of cancer death globally, with 1.86 million deaths in 2024.
-
Approximately 1 in 5 people worldwide will develop cancer during their lifetime.
-
30–50% of cancers are preventable through lifestyle changes and vaccination.
-
More than 45% of cancer patients experience financial hardship, and over half report mental health challenges.
-
Five-year survival for breast cancer ranges from 87% in high-income countries to 42% in low-income countries.
❓ Questions and Answers
What is cancer?
Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells. These cells can invade nearby tissues and spread to distant organs through the bloodstream or lymphatic system.
Can cancer be inherited?
Most cancers are not inherited. However, about 5–10% of cancers are linked to inherited gene mutations. Genetic testing can identify individuals at high risk.
Is cancer contagious?
No, cancer is not contagious. You cannot catch cancer from another person. However, some infections that increase cancer risk (e.g., HPV, hepatitis B) can be transmitted.
Can cancer be prevented?
Yes. Approximately 30–50% of cancers are preventable through lifestyle modifications such as avoiding tobacco, maintaining a healthy weight, limiting alcohol, getting vaccinated against HPV and hepatitis B, and participating in screening programs.
What is the difference between benign and malignant tumors?
Benign tumors are non-cancerous. They do not spread and are usually not life-threatening. Malignant tumors are cancerous; they can invade surrounding tissues and metastasize.
What are the most common treatments for cancer?
The main treatment modalities are surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, and hormone therapy. Treatment is often multimodal.
What does “stage” mean in cancer?
Staging describes the extent of cancer in the body. It is based on the size of the primary tumor (T), involvement of lymph nodes (N), and presence of metastasis (M). Stages range from 0 (in situ) to IV (metastatic).
Can metastatic cancer be cured?
Metastatic cancer is generally not considered curable with current treatments, but it can often be controlled with systemic therapies, allowing patients to live for years with good quality of life. In some cases, oligometastatic disease (limited metastases) may be amenable to curative-intent treatment.
What is immunotherapy?
Immunotherapy is a type of cancer treatment that helps the immune system recognize and attack cancer cells. It includes checkpoint inhibitors, CAR-T cell therapy, and monoclonal antibodies.
How does chemotherapy work?
Chemotherapy uses drugs that target rapidly dividing cells. Because cancer cells divide more frequently than most normal cells, they are more susceptible to these drugs. However, chemotherapy can also affect normal rapidly dividing cells, causing side effects.
What is the 5-year survival rate?
The 5-year survival rate is the percentage of people diagnosed with a specific cancer who are still alive five years after diagnosis. It is a statistical measure and does not predict individual outcomes.
Does a positive family history mean I will get cancer?
No. Most people with a family history of cancer do not develop the disease. However, a family history may increase risk, and genetic counseling may be recommended.
🎯 Key Takeaways and Conclusions
-
Cancer is a complex group of diseases characterized by uncontrolled cell growth and the ability to invade and metastasize. It is classified under ICD-10 codes C00–C97.
-
Types include carcinomas, sarcomas, lymphomas, leukemias, and central nervous system cancers, with lung, breast, colorectal, and prostate cancers being the most common globally.
-
Causes are multifactorial, involving genetic predisposition, environmental carcinogens, infections, and lifestyle factors. Tobacco use remains the single largest preventable cause.
-
Prevention is highly effective: up to half of all cancers can be prevented through lifestyle changes, vaccination, and screening.
-
Early detection through screening significantly improves survival. Warning signs such as unexplained weight loss, persistent pain, and abnormal bleeding should never be ignored.
-
Diagnosis relies on imaging (CT, MRI, PET), biopsy, and laboratory tests. Biopsy is the gold standard.
-
Treatment is multimodal and may include surgery, radiation, chemotherapy, targeted therapy, immunotherapy, and hormone therapy. Treatment plans are personalized based on cancer type, stage, and molecular profile.
-
Staging using the TNM system guides prognosis and treatment decisions. Stage IV indicates metastatic disease.
-
Metastasis is the spread of cancer to distant organs and is the leading cause of cancer death.
-
Survival rates have improved dramatically, with the overall 5-year survival rate for all cancers now at 70%. However, outcomes vary widely by cancer type, stage, and access to care.
-
Life expectancy without treatment is generally poor, underscoring the importance of timely diagnosis and intervention.
-
Facts and statistics reveal a growing global burden, with an estimated 35 million new cases projected by 2050. Addressing inequities in cancer care is a global priority.
Cancer remains one of the most significant health challenges of our time, but with continued research, prevention, early detection, and equitable access to treatment, the burden of this disease can be substantially reduced.
📚 References
-
World Health Organization. Cancer Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/cancer
-
National Cancer Institute. What Is Cancer? https://www.cancer.gov/about-cancer/understanding/what-is-cancer
-
Centers for Disease Control and Prevention. Cancer Screening Tests. https://www.cdc.gov/cancer/prevention/screening.html
-
American Cancer Society. Cancer Facts & Figures. https://www.cancer.org/research/cancer-facts-statistics.html
-
MSD Manual Consumer Version. Risk Factors for Cancer. https://www.msdmanuals.com/home/quick-facts-cancer/overview-of-cancer/risk-factors-for-cancer
-
MSD Manual Consumer Version. Warning Signs of Cancer. https://www.msdmanuals.com/home/cancer/overview-of-cancer/warning-signs-of-cancer
-
MSD Manual Professional Version. Overview of Cancer Therapy. https://www.msdmanuals.com/professional/oncologie/principes-thérapeutiques-en-oncologie/revue-générale-du-traitement-des-cancers
-
National Cancer Institute. SEER Cancer Statistics Review. https://seer.cancer.gov/
-
World Health Organization. WHO calls for urgent action as new cancer cases are projected to nearly double by 2050. https://www.who.int/news/item/08-07-2026-who-calls-for-urgent-action-as-new-cancer-cases-are-projected-to-nearly-double-by-2050
-
American Cancer Society. Cancer Statistics Center. https://cancerstatisticscenter.cancer.org/
-
National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology. https://www.nccn.org/guidelines
-
U.S. Preventive Services Task Force. Cancer Screening Recommendations. https://www.uspreventiveservicestaskforce.org/
-
International Agency for Research on Cancer (IARC). GLOBOCAN 2024. https://gco.iarc.fr/
-
National Cancer Institute. SEER Stat Fact Sheets. https://seer.cancer.gov/statfacts/
-
American Society of Clinical Oncology (ASCO). Cancer.Net. https://www.cancer.net/
-
European Society for Medical Oncology (ESMO). Clinical Practice Guidelines. https://www.esmo.org/guidelines
-
National Institute for Health and Care Excellence (NICE). Cancer Guidelines. https://www.nice.org.uk/guidance/conditions-and-diseases/cancer
-
Centers for Disease Control and Prevention. Cancer Prevention and Control. https://www.cdc.gov/cancer/
-
National Cancer Institute. Cancer Treatment. https://www.cancer.gov/about-cancer/treatment
-
World Cancer Research Fund. Cancer Prevention Recommendations. https://www.wcrf.org/dietandcancer
-
American Institute for Cancer Research. Cancer Risk Factors. https://www.aicr.org/cancer-research/
-
National Cancer Institute. Metastatic Cancer. https://www.cancer.gov/types/metastatic-cancer
-
National Cancer Institute. Immunotherapy. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy
-
National Cancer Institute. Targeted Therapy. https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies
-
National Cancer Institute. Chemotherapy. https://www.cancer.gov/about-cancer/treatment/types/chemotherapy
-
National Cancer Institute. Radiation Therapy. https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy
-
National Cancer Institute. Surgery. https://www.cancer.gov/about-cancer/treatment/types/surgery
-
American Cancer Society. Survival Rates for Breast Cancer. https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html
-
National Cancer Institute. Cancer Staging. https://www.cancer.gov/about-cancer/diagnosis-staging/staging
-
Union for International Cancer Control (UICC). TNM Classification of Malignant Tumours. https://www.uicc.org/resources/tnm
-
World Health Organization. International Classification of Diseases (ICD-10). https://icd.who.int/
-
National Cancer Institute. Cancer Genetics. https://www.cancer.gov/about-cancer/causes-prevention/genetics
-
Centers for Disease Control and Prevention. HPV and Cancer. https://www.cdc.gov/cancer/hpv/
-
World Health Organization. Hepatitis B. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
-
National Cancer Institute. Helicobacter pylori and Cancer. https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/h-pylori
-
American Cancer Society. Diet and Physical Activity. https://www.cancer.org/healthy/eat-healthy-get-active.html
-
National Cancer Institute. Tobacco and Cancer. https://www.cancer.gov/about-cancer/causes-prevention/risk/tobacco
-
World Health Organization. Alcohol and Cancer. https://www.who.int/news-room/fact-sheets/detail/alcohol
-
National Cancer Institute. Radiation and Cancer. https://www.cancer.gov/about-cancer/causes-prevention/risk/radiation
-
National Cancer Institute. Environmental Carcinogens. https://www.cancer.gov/about-cancer/causes-prevention/risk/substances
-
American Cancer Society. Cancer Screening Guidelines. https://www.cancer.org/healthy/find-cancer-early/cancer-screening-guidelines.html
-
National Cancer Institute. Cancer Diagnosis. https://www.cancer.gov/about-cancer/diagnosis-staging
-
National Cancer Institute. Biopsy. https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/biopsy
-
National Cancer Institute. Tumor Markers. https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/tumor-markers
-
American Society of Clinical Oncology. Understanding Cancer Staging. https://www.cancer.net/navigating-cancer-care/diagnosing-cancer/stages-cancer
-
National Cancer Institute. Metastatic Cancer: Questions and Answers. https://www.cancer.gov/types/metastatic-cancer
-
World Health Organization. Global Status Report on Cancer 2026. https://www.who.int/publications/i/item/9789240123977
-
American Cancer Society. Cancer Survival Rates. https://www.cancer.org/cancer/survival-rates.html
-
National Cancer Institute. Life Expectancy After Cancer Diagnosis. https://www.cancer.gov/about-cancer/understanding/statistics
-
World Cancer Day. Facts and Figures. https://www.worldcancerday.org/
Was it helpfull? Rate this article:




(No Ratings Yet)
Loading...